Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05527158
Other study ID # 52018
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2021
Est. completion date December 2022

Study information

Verified date August 2022
Source Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Contact JIANG Quan, M.D
Phone +8613901081632
Email doctorjq@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a single-blinded, randomized, parallel controlled trial.The purpose of this experiment is to confirm how "Yijinjing" treatment affects hand function, handgrip strength, pain, morning stiffness, and mood disorder in RA patients compared to routine care.


Description:

To compare the efficacy of Traditional Chinese Exercise Yijinjing and routine care on hand dysfunction,which is the clinical challenge in rheumatoid arthritis (RA), a single- centre,single-blinded, randomized controlled trial will be conducted. Sixty-six RA patients will be randomly allocated (1:1) to treatment with Yijinjing exercise or routine care. The primary outcome is a 10% improvement in the Michigan Hand Outcomes Questionnaire (MHQ) at week 12.


Recruitment information / eligibility

Status Recruiting
Enrollment 66
Est. completion date December 2022
Est. primary completion date December 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. meet the RA criteria by the American College of Rheumatology(ACR)/the European League Against Rheumatism(EULAR) in 2010 or the ACR in 1987 2. between the ages of 18 and 65, regardless of gender 3. DAS28=3.2 4. joint function in grades I to II or X-ray in stages I to II 5. no use or maintenance of a stable dose of DMARDs, biological agents, or hormones within 4 weeks prior to screening 6. wrist joints or finger joints (MCP, PIP) were swollen or painful 7. tested for hand dysfunction by a professional rheumatologist 8. volunteer to participate Exclusion Criteria: 1. Yijinjing exercise experience within the last 3 months 2. severe joint deformity (including subluxation and severe ulnar deviation) and joint ankylosis 3. other diseases affecting limb function such as trauma, fractures, infections, tumors, congenital malformations 4. present with complication diseases such as serious cardiovascular, brain, liver, lung, kidney, and hematopoietic system diseases 5. a moderate or severe cognitive impairment that unable to cooperate with the treatment 6. unwilling to join

Study Design


Intervention

Behavioral:
Yi Jin Jing exercise
Yi Jin Jing of The General Administration of Sport of China, which consists of twelve operational processes as the standard intervention

Locations

Country Name City State
China Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing

Sponsors (1)

Lead Sponsor Collaborator
Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Michigan Hand Outcomes Questionnaire (MHQ) The Michigan Hand Outcomes Questionnaire(MHQ) consists of 37 questions about six categories:(1) overall hand function; (2) activities of daily living; (3) work performance; (4) pain; (5) aesthetics; and (6) patient satisfaction with hand function, measured individually for the left and right hands. Each item is given a value between 0 and 100, with higher scores indicating superior function and higher pain ratings denoting more intense pain. week 12
Secondary Pain Visual Analogue Scale 0 signifying "no pain" and 10 signifying "the worst intolerable agony" week 12
Secondary The number of swollen joints, painful joints, and deformed joints Number of the following 28 joints: elbows, shoulders, elbow, wrists, metacarpal- phalangeal I-V, proximal interphalangeal I-V and knees which are swollen, painful or deformed. week 12
Secondary Morning stiffness duration The time (minutes) of the patient's self-reported morning stiffness week 12
Secondary Handgrip strength An electronic gripper will be used to assess handgrip strength (kg). Be carried out three times, the final result set by the average value. week 12
Secondary Range of motion(ROM) Use a protractor to calculate the wrist flexion, dorsiflexion, ulnar deviation, radial deviation, MCP flexion, PIP flexion, and finger dorsiflexion angles(°). week 12
Secondary Health Assessment Questionnaire Disability Index(HAQ) Health Assessment Questionnaire Disability Index(HAQ) contains 20 questions about daily activities such as dressing, brushing, getting up, eating, strolling, maintaining personal hygiene, touching, and holding. For each question, there is a four level that is scored from 0 (without any difficulty) to 3 (unable to do). week 12
Secondary The Self-rating anxiety scale (SAS) The Self-rating Anxiety Scale (SAS) mainly consists of 20 items rated on a 4-point scale that from 0(no or little time) to 3(most or all of time). week 12
Secondary The self-rating depression scale (SDS) The Self-rating Anxiety Scale (SAS) mainly consists of 20 items rated on a 4-point scale that from 0(no or little time) to 3(most or all of time). week 12
Secondary Wrist joint ultrasonography Outcome Measures in Rheumatology (OMERACT) score Using the EULAR-OMERACT to classify rheumatoid arthritis synovitis and tenosynovitis. week 12
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4